Tumour Angiogenesis and Angiogenic Inhibitors: A Review

Angiogenesis is a complex process depending on the coordination of many regulators and there by activating angiogenic switch. Recent advances in understanding of angiogenic mechanism have lead to the development of several anti-angiogenic and anti-metastatic agents that use the strategy of regulatio...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical and diagnostic research 2015-06, Vol.9 (6), p.XE01-XE05
Main Authors: Yadav, Lalita, Puri, Naveen, Rastogi, Varun, Satpute, Pranali, Sharma, Vandana
Format: Article
Language:English
Subjects:
angiogenic switch
angiostatin
interleukin
Oncology Section
vegf
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Angiogenesis is a complex process depending on the coordination of many regulators and there by activating angiogenic switch. Recent advances in understanding of angiogenic mechanism have lead to the development of several anti-angiogenic and anti-metastatic agents that use the strategy of regulation of angiogenic switch. Antiangiogenic therapy is a form of treatment not cure for cancer and represents a highly effective strategy for destroying tumour because vascular supply is the fundamental requirement for growth of tumour. Because of the quiescent nature of normal adult vasculature, angiogenic inhibitors are expected to confer a degree of specificity when compared to nonspecific modalities of chemo and radiotherapy, so it has the advantage of less toxicities, does not induce drug resistance and deliver a relatively non toxic, long term treatment of tumour.
ISSN:2249-782X
0973-709X
DOI:10.7860/JCDR/2015/12016.6135